Evidence map›Paper›PMID 27687249›Full record

ArticleNature communications2016

Dichotomy of cellular inhibition by small-molecule inhibitors revealed by single-cell analysis.

Robert M Vogel, Amir Erez, Grégoire Altan-Bonnet

Abstract read
In one paragraph

Article in Nature communications, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Modeling of cytometry data in logarithmic space: When is a bimodal distribution not bimodal?Cytometry. Part A : the journal of the International Society for Analytical Cytology · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Robert M VogelImmunoDynamics Group, Program in Computational Biology and Immunology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, Box 460, New York, New York 10065, USA.
Amir ErezImmunoDynamics Group, Program in Computational Biology and Immunology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, Box 460, New York, New York 10065, USA.
Grégoire Altan-BonnetImmunoDynamics Group, Program in Computational Biology and Immunology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, Box 460, New York, New York 10065, USA.

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Nicholas D Socci · 1985 to 2026
$347.4M
Variability of Cellular Responses to Growth Factors and Drugs During TumorgenesisU54CA148967 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI ALTAN-BONNET, GREGOIRE · 2010 to 2014
$13.8M
Phenotypic variability within isogenic population of lymphocytesZIABC011726 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI ALTAN-BONNET, GRÉGOIRE · 2016 to 2025
$3.9M
NCI NIH HHS P30 CA008748NCI NIH HHS U54 CA148967
6 · The paper itself

Abstract

Despite progress in drug development, a quantitative and physiological understanding of how small-molecule inhibitors act on cells is lacking. Here, we measure the signalling and proliferative response of individual primary T-lymphocytes to a combination of antigen, cytokine and drug. We uncover two distinct modes of signalling inhibition: digital inhibition (the activated fraction of cells diminishes upon drug treatment, but active cells appear unperturbed), versus analogue inhibition (the activated fraction is unperturbed whereas activation response is diminished). We introduce a computational model of the signalling cascade that accounts for such inhibition dichotomy, and test the model predictions for the phenotypic variability of cellular responses. Finally, we demonstrate that the digital/analogue dichotomy of cellular response as revealed on short (signal transduction) timescales, translates into similar dichotomy on longer (proliferation) timescales. Our single-cell analysis of drug action illustrates the strength of quantitative approaches to translate in vitro pharmacology into functionally relevant cellular settings.

Identifiers

PMID27687249
PMCPMC5056434

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.